News

Cyprus has the most competitive IP-box regime in the European Union — and following the 2026 tax reform that raised the corporate rate to 15%, the effective tax rate on qualifying IP income is now approximately 3%. For SaaS companies, life-sciences groups, patent holders and software-IP businesses, the maths still work spectacularly well, provided the structure satisfies the OECD’s modified-nexus approach. This guide explains how the Cyprus IP Box works in 2026, who qualifies, how to calculate the relief, and the substance you need in place.

The Cyprus IP Box in 2026: What Changed

The Cyprus IP Box itself was not directly amended by the 2026 tax reform. What changed is the underlying corporate income tax rate against which the 80% deduction is applied:

• Pre-2026: 12.5% × (100% − 80%) = 2.5% effective rate on qualifying IP income.
• From 1 January 2026: 15% × (100% − 80%) = 3% effective rate on qualifying IP income.

Even at 3%, Cyprus remains materially below the IP-box rates in Ireland (6.25%), the Netherlands (9%) and most other EU jurisdictions, and is competitive with the world’s top destinations for tax-efficient IP ownership. Our companion Cyprus corporate income tax guide covers the full 2026 reform context.

What Qualifies as IP Under the Cyprus IP Box?

The Cyprus IP Box is restricted to assets that satisfy the OECD’s modified nexus approach. Only the following qualify:

• Patents and patent applications.
• Software protected by copyright (a critical category for SaaS and tech businesses).
• Utility models, plant variety rights and orphan drug designations.
• Other functionally equivalent IP certified as such by the relevant patent office.

What does NOT qualify: Marketing-related IP — trademarks, brand names, image rights, and similar marketing assets. This is a deliberate carve-out under the OECD modified nexus to prevent “brand-shopping.”

What Income Qualifies for the 80% Deduction?

Once an asset is qualifying, the income streams that benefit from the 80% deduction are:

• Royalties received from licensing the IP.
• Embedded IP income — the portion of revenue from selling a product/service that is attributable to the underlying IP (subject to transfer-pricing documentation).
• Capital gains on the disposal of qualifying IP are fully exempt from corporate tax (better than the 80% deduction).
• Compensation for IP infringement.

Marketing and sales income, services income that is not IP-derived, and income from disqualifying assets do not benefit from the deduction.

The Nexus Fraction — How Relief is Actually Calculated

The OECD modified nexus approach links the size of the IP-box benefit to the share of R&D the company itself has performed. The formula:

Where:

• Qualifying expenditure = R&D performed by the Cyprus company itself, plus R&D outsourced to unrelated parties.
• Overall expenditure = Qualifying expenditure + acquisition cost of the IP + R&D outsourced to related parties.
• The ×1.30 uplift partially compensates for any acquisition or related-party outsourcing costs, capped so the nexus fraction never exceeds 100%.

Worked Example 1: Pure in-house R&D

A Cyprus company develops software entirely in-house. €1m of R&D expenditure, no acquisitions, no related-party outsourcing.

• Qualifying expenditure: €1m
• Overall expenditure: €1m
• Nexus fraction: (1.0 × 1.30) ÷ 1.0 = capped at 100%
• If IP profit is €500,000 → all €500,000 qualifies for the 80% deduction → €100,000 taxable at 15% → €15,000 tax (3% effective)

Worked Example 2: Partial third-party outsourcing

Cyprus company spends €600k on in-house R&D and €400k on a third-party R&D contractor (unrelated).

• Qualifying expenditure: €600k + €400k = €1m
• Overall expenditure: €1m
• Nexus fraction: 100% — third-party R&D is qualifying
• Same outcome as Example 1.

Worked Example 3: Acquired IP with some in-house R&D

Cyprus company acquires existing IP for €500k and spends a further €500k on in-house R&D.

• Qualifying expenditure: €500k
• Overall expenditure: €1m (acquisition + in-house)
• Nexus fraction: (0.5 × 1.30) ÷ 1.0 = 65%
• If IP profit is €500,000 → only €325,000 qualifies for the 80% deduction. Result: blended effective rate above 3% but still very low.

R&D Substance Requirements

The Cyprus IP Box is OECD-modified-nexus compliant precisely because it ties relief to real R&D activity. To defend the structure you need:

• Management and control in Cyprus — strategic R&D decisions taken by the Cyprus board.
• Qualified Cyprus directors with industry or technical credibility for the IP being developed.
• Office and substance — physical premises (or a credible serviced office), local employees or contractors involved in R&D.
• R&D contracts and invoices — clear paper trail for in-house and outsourced work.
• Ownership documentation — clear legal title to the IP held by the Cyprus company, with assignment agreements where IP originated elsewhere.

For most operating businesses, a part-time local director plus a service agreement with a Cyprus operator (and a credible address) is the minimum. For larger operations, hiring R&D staff locally materially strengthens the position.

Capital Gains on Disposal of Qualifying IP

One often-overlooked feature: profits from the sale of qualifying IP are fully exempt from corporate income tax in Cyprus — better than the 80% deduction on ongoing royalty income. For acquirer-side strategies (acquire-and-hold for a future trade sale), this matters enormously. The capital-gains exemption is a key reason Cyprus is used for IP-holding structures preparing for exit.

Setting Up a Cyprus IP-Box Structure

The typical setup sequence is:

1. Cyprus company formation — see our company formation guide.
2. IP assignment or development — transfer existing IP via assignment agreement, or develop new IP from day one in the Cyprus entity.
3. R&D substance — appoint Cyprus directors and company secretary, secure premises, plan local R&D activity.
4. Transfer-pricing documentation — defensible pricing for related-party R&D and any embedded-IP allocations.
5. Bookkeeping & audit — clean records demonstrating the qualifying expenditure, nexus fraction and overall IP profit. See our bookkeeping requirements guide.
6. Annual TD4 filing with the IP-box claim, supported by the nexus calculation.

Common Pitfalls

• Marketing IP creep — trying to bring trademarks or brands inside the regime. They don’t qualify.
• Weak substance — no local director, no office, all R&D outsourced to related parties. The nexus fraction collapses and the regime can be challenged.
• Poor documentation — claiming the deduction without supporting R&D records, contracts and invoices.
• Acquisition without uplift planning — buying existing IP without subsequent in-house R&D drags down the nexus fraction.
• Mis-pricing embedded IP — overclaiming the IP-attributable portion of product/service revenue without defensible transfer-pricing analysis.

How KTC Sets Up and Runs Cyprus IP-Box Structures

KTC Business Consultants has been advising IP-driven groups on Cyprus structures for more than 20 years. We deliver:

• IP-eligibility review and nexus modelling before you commit to Cyprus.
• Company formation with Cyprus-resident directors and substance planning.
• Drafting of IP assignment agreements, R&D services agreements and transfer-pricing documentation.
• Annual TD4 filing including the IP-box claim and supporting nexus calculation.
• Coordination with our ICPAC-licensed audit team for clean statutory audits.
• Exit support — capital-gains exempt sale planning.

If you are still incorporating, our Cyprus company formation service bundles incorporation with IP-box positioning from day one.

Frequently Asked Questions

What is the effective tax rate under the Cyprus IP Box in 2026?

Approximately 3% on qualifying IP income (15% CIT × 20% — because 80% of qualifying profit is deducted from the tax base). Capital gains on the disposal of qualifying IP are fully exempt.

Does the Cyprus IP Box cover trademarks and brands?

No. Marketing-related IP (trademarks, brand names, image rights) is excluded by the OECD modified nexus approach. Cyprus follows the same exclusion.

Does software qualify for the Cyprus IP Box?

Yes — software protected by copyright is one of the most common qualifying assets, particularly for SaaS, fintech and infrastructure-software businesses. The asset needs to be properly developed and documented as the company’s property.

What is the nexus fraction?

A ratio that links the IP-box benefit to the share of R&D the Cyprus company has actually performed (or paid unrelated parties to perform). Qualifying expenditure is multiplied by 1.30 (uplift) and divided by overall expenditure (which includes acquisition cost and related-party outsourcing). The fraction is capped at 100%.

What substance do I need in Cyprus to claim the IP Box?

At minimum: a Cyprus-resident director, a credible office address, R&D management and decision-making in Cyprus, and contemporaneous R&D contracts and records. Larger operations should add local R&D staff or contractors.

Are capital gains on the sale of IP taxable?

Capital gains on the disposal of qualifying IP are fully exempt from Cyprus corporate income tax — a key benefit when planning a future trade sale.

What about Pillar Two for large IP-holding groups?

Only groups with consolidated revenue above €750m are in scope. For in-scope groups, the IP Box’s effective 3% rate can trigger top-up tax in another jurisdiction. KTC works with in-scope groups on the GloBE rules and structure adjustments.